A detailed history of Imc Chicago, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Imc Chicago, LLC holds 14,324 shares of LLY stock, worth $11.4 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
14,324
Holding current value
$11.4 Million
% of portfolio
0.42%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$772.14 - $960.02 $11.1 Million - $13.8 Million
14,324 New
14,324 $12.7 Million
Q1 2019

May 15, 2019

SELL
$111.31 - $131.02 $456,704 - $537,575
-4,103 Closed
0 $0
Q4 2018

Apr 24, 2019

BUY
$105.9 - $118.64 $434,507 - $486,779
4,103 New
4,103 $475,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Imc Chicago, LLC Portfolio

Follow Imc Chicago, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Imc Chicago, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Imc Chicago, LLC with notifications on news.